NDRI researchers evaluate prison Hepatitis programMarch 03, 2006In an article published in the Journal of Correctional Health Care, researchers from the National Development and Research Institutes, Inc. (NDRI) reported on an evaluation of an intervention program within a prison system addressing Hepatitis C virus (HCV). Findings include recommendations for increasing Hepatitis C education and staff training, and expanding peer educators programming. Hepatitis C virus is the most common chronic blood transmitted infectious disease in the United States today. The incidence is even higher among inmates in correctional facilities, with about a 9 times greater rate of infection. In addition, previous studies indicated that among those in the general population with the virus, a third or more pass through a correctional facility within a year's period. For those maximizing the public health impact of preventive and treatment interventions, the correctional facility is a vital location; and for those running correctional facilities or setting policy in the criminal justice area, attention to the public health impact of Hepatitis C has become extremely important. Researchers at NDRI examined the HCV-related educational, testing, and medical services offered within a drug treatment program at a correctional facility in California. The study describes the services offered, assesses client and staff perceptions of the advantages, benefits, and barriers to delivering services, and made recommendations for the future.
"This approach presents a tremendous opportunity to limit the spread of HCV," noted Dr. Shiela Strauss, one of the authors. Yet such programs do not exist at many correctional facilities. The authors also recommend the relatively low cost and sustainable approach of peer to peer educational programs to address this pressing public health challenge within the budget limitations of many correctional programs. National Development & Research Institutes | |||||||||||||||||||||
|
Related Hepatitis C News Articles Early trigger for type-1 diabetes found in mice, Stanford scientists report Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins. Trapping white blood cells proves novel strategy against chronic viral infections Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found. Trapping white blood cells proves novel strategy against chronic viral infections Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found. Early treatment is key to combating hepatitis C virus Canadian researchers have shown that patients who receive early treatment for Hepatitis C virus (HCV) within the first months following an infection, develop a rapid poly-functional immune response against HCV similar to when infection is erradicted spontaneously, according to a new study published in the Journal of Virology. Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the efficacy of imiquimod, a clinically important immune response modifier with potent antiviral and antitumor activity, is dependent on the Opioid Growth Factor (OGF)-OGF receptor (OGFr) axis for its action. Researchers disprove long-standing belief about HIV treatment Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail." New Guidelines for Treating Rheumatoid Arthritis Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham (UAB). Older liver donors not associated with negative outcomes in transplant recipients with hepatitis C Receiving a liver from a donor older than age 60 does not appear to be associated with transplant failure, death or recurrent disease in the next five years among transplant patients with the hepatitis C virus. Hepatitis C virus may need enzyme's help to cause liver disease A key enzyme may explain how hepatitis C infection causes fatty liver - a buildup of excess fat in the liver, which can lead to life-threatening diseases such as cirrhosis and liver cancer, report University of Pittsburgh Graduate School of Public Health and School of Medicine researchers. How to increase the chances of remaining virus free Pakistani patients with HCV? Hepatitis C is a health care problem all over the world, with 130 million patients infected the world over. The treatment is expensive and has variable results according to the genotype of the infecting virus. More Hepatitis C News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||